Home » Ranbaxy Forays Into Authorised Generics in U.S.
Ranbaxy Forays Into Authorised Generics in U.S.
Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR — an antihypertensive agent — in the U.S. market.
The Economic Times
Upcoming Events
-
07May
-
14May
-
30May